Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04421274Phase 3Completed
A Phase 3 trial of autologous bone-marrow mesenchymal stem cells in ST-segment elevation myocardial infarction (STEMI), sponsored by Affiliated Hospital of North Sichuan Medical College. Started May 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04421274.